ghk cu clinical trial skin elasticity randomized How GHK-Cu Tightens Loose Skin: Evidence & Protocols Epigenetic mechanisms activated by GHK-Cu

Clin Diagn Lab Immunol 8(3):545551

BPC-157's hepatoprotection is extensive, acting in acute, chronic, and even advanced stages of liver disease, and administration of the peptide both parenterally and orally is a practical and convenient option for liver protection

Putting the Results in Context The improvement seen in the active group (2650% on the investigator scale) over 6 months is encouraging, but context is essential: The improvement level is broadly comparable to other copper peptide studies, though direct comparison is difficult because this study used a categorical improvement scale rather than exact hair counts

doi: 10.1001/jama.250.14.1886